Abstract Library

The summaries are free for public use. ARTHROS will continue to add and archive summaries of articles deemed relevant to ARTHROS by our Faculty.

1

Interstitial Lung Disease Worsens Short- and Long-Term Outcomes of Systemic Rheumatic Disease Patients Admitted to the ICU: A Multicenter Study

J Clin Med. 2021 Mar 3;10(5):1037. doi: 10.3390/jcm10051037.

Lorrain Banuls 1Juliette Vanoverschelde 2Fanny Garnier 1Matthieu Amalric 1Samir Jaber 3 4Jonathan Charbit 5Kevin Chalard 6Marc Mourad 4 7Nacim Benchabane 1 4Racim Benomar 1Noemie Besnard 1Delphine Daubin 1Vincent Brunot 1Kada Klouche 1 4Romaric Larcher 1 4

2

Renal Arteries Revisited: Anatomy, Pathologic Entities, and Implications for Endovascular Management

Radiographics. May-Jun 2021;41(3):909-928. doi: 10.1148/rg.2021200162.

Richard D White 1Katherine S Moore 1M Ghali Salahia 1W Rhodri Thomas 1Andrew C Gordon 1Ian M Williams 1Andrew M Wood 1Ian A Zealley 1

3

Antineutrophil Cytoplasmic Antibody-associated Vasculitis Management 2020: Where Are We Now?

 

J Rheumatol. 2021 Mar 1;jrheum.201351. doi: 10.3899/jrheum.201351.Online ahead of print.

David Jayne 1

4

Glucocorticoid maintenance therapy and severe infectious complications in ANCA-associated vasculitis: a retrospective analysis

Rheumatol Int. 2021 Feb;41(2):431-438. doi: 10.1007/s00296-020-04752-9. Epub 2020 Nov 22.

Claudius Speer 1Christine Altenmüller-Walther 2Jan Splitthoff 3Christian Nusshag 2Florian Kälble 2Paula Reichel 2Christian Morath 2Martin Zeier 2Raoul Bergner 3Matthias Schaier 2

5

Rituximab, Cyclophosphamide, and Corticosteroids for ANCA Vasculitis: The Good, the Bad, and the Ugly

Kidney Blood Press Res. 2020;45(6):784-791. doi: 10.1159/000509608.Epub 2020 Oct 12.

Roberta Fenoglio 1Dario Roccatello 2Savino Sciascia 1

6

The role of plasma exchange in antineutrophil cytoplasmic antibody-associated vasculitis: a meta-analysis

Clin Rheumatol. 2021 Apr;40(4):1447-1456. doi: 10.1007/s10067-020-05390-z.Epub 2020 Sep 15.

Ioannis Bellos 1Ioannis Michelakis 2Dionysis Nikolopoulos 3 4

7

Small vessel vasculitis secondary to Mycobacterium chelonae

Rheumatol Int. 2020 Sep 5. doi: 10.1007/s00296-020-04697-z.Online ahead of print.

Monica Weinberg 1Ayse Bag-Ozbek 2 3Davina Chen 1Qingping Yao 1

8

Neutrophil Extracellular Traps: A Potential Therapeutic Target in MPO-ANCA Associated Vasculitis?

Front Immunol. 2021 Mar 15;12:635188. doi: 10.3389/fimmu.2021.635188.eCollection 2021.

Kim M O'Sullivan 1Stephen R Holdsworth 1 2 3

9

Rituximab-associated hypogammaglobulinemia in autoimmune rheumatic diseases: a single-center retrospective cohort study

Rheumatol Int. 2021 Apr 3;1-10. doi: 10.1007/s00296-021-04847-x. Online ahead of print.

Stefanie D Wade 1Vasileios C Kyttaris 2

10

Pregnancy Outcomes in Systemic Vasculitides

Curr Rheumatol Rep. 2020 Aug 26;22(10):63. doi: 10.1007/s11926-020-00940-5.

Carolyn Ross 1Rohan D'Souza 2Christian Pagnoux 3

11

Randomized clinical trials in ANCA-associated vasculitis: a systematic analysis of the WHO - International Clinical Trials Registry Platform

Orphanet J Rare Dis. 2020 May 29;15(1):130. doi: 10.1186/s13023-020-01408-6.

Michele Iudici 1Xavier Puéchal 2Alejandro Brigante 3Ignacio Atal 4Cem Gabay 5

12

Association between age at disease onset of anti-neutrophil cytoplasmic antibody-associated vasculitis and clinical presentation and short-term outcomes

Rheumatology (Oxford). 2021 Feb 1;60(2):617-628. doi: 10.1093/rheumatology/keaa215.

Sara Monti 1 2Anthea Craven 3Catherine Klersy 4Carlomaurizio Montecucco 1Roberto Caporali 1Richard Watts 5Peter A Merkel 6Raashid Luqmani 3DCVAS Collaborators

 

13

ANCA autoantigen gene expression highlights neutrophil heterogeneity where expression in normal-density neutrophils correlates with ANCA-induced activation

Kidney Int. 2020 Sep;98(3):744-757. doi: 10.1016/j.kint.2020.04.037. Epub 2020 May 21.

Britta E Jones 1Carolina A Herrera 1Christian Agosto-Burgos 1Joshua Starmer 2William A Bass 1Caroline J Poulton 1Lauren Blazek 1Candace D Henderson 1Yichun Hu 1Susan L Hogan 1Peiqi Hu 3Hong Xiao 3Eveline Y Wu 4Dhruti P Chen 1J Charles Jennette 5Meghan E Free 1Ronald J Falk 6Dominic J Ciavatta 7

14

Pathogenesis of ANCA-associated vasculitis: an emerging role for immunometabolism

Rheumatology (Oxford). 2020 May 1;59(Suppl 3):iii33-iii41.doi: 10.1093/rheumatology/keaa023.

Emma Leacy 1Gareth Brady 1Mark A Little 1

15

Reducing the initial number of rituximab maintenance-therapy infusions for ANCA-associated vasculitides: randomized-trial post-hoc analysis

Rheumatology (Oxford). 2020 Oct 1;59(10):2970-2975.doi: 10.1093/rheumatology/kez621.

Pierre Charles 1 2Agnès Dechartres 3Benjamin Terrier 1Pascal Cohen 1Stanislas Faguer 4Antoine Huart 4Mohamed Hamidou 5Christian Agard 5Bernard Bonnotte 6Maxime Samson 6Alexandre Karras 7Noémie Jourde-Chiche 8François Lifermann 9Pierre Gobert 10Catherine Hanrotel-Saliou 11Pascal Godmer 12Nicolas Martin-Silva 13Grégory Pugnet 14Marie Matignon 15Olivier Aumaitre 16Jean-François Viallard 17François Maurier 18Nadine Meaux-Ruault 19Sophie Rivière 20Jean Sibilia 21Xavier Puéchal 1Luc Mouthon 1Loïc Guillevin 1French Vasculitis Study Group

16

Association of Cigarette Smoking With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis

JAMA Intern Med. 2020 Jun 1;180(6):870-876.doi: 10.1001/jamainternmed.2020.0675.

Greg McDermott 1Xiaoqing Fu 2 3John H Stone 1 4Rachel Wallwork 1 4Yuqing Zhang 1 2 4 3Hyon K Choi 1 2 4 3Zachary S Wallace 1 2 4 3

17

Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis

N Engl J Med. 2020 Feb 13;382(7):622-631.doi: 10.1056/NEJMoa1803537.

Michael Walsh 1Peter A Merkel 1Chen-Au Peh 1Wladimir M Szpirt 1Xavier Puéchal 1Shouichi Fujimoto 1Carmel M Hawley 1Nader Khalidi 1Oliver Floßmann 1Ron Wald 1Louis P Girard 1Adeera Levin 1Gina Gregorini 1Lorraine Harper 1William F Clark 1Christian Pagnoux 1Ulrich Specks 1Lucy Smyth 1Vladimir Tesar 1Toshiko Ito-Ihara 1Janak Rashme de Zoysa 1Wojciech Szczeklik 1Luis Felipe Flores-Suárez 1Simon Carette 1Loïc Guillevin 1Charles D Pusey 1Alina L Casian 1Biljana Brezina 1Andrea Mazzetti 1Carol A McAlear 1Elizabeth Broadhurst 1Donna Reidlinger 1Samir Mehta 1Natalie Ives 1David R W Jayne 1PEXIVAS Investigators

 

  • PEXIVAS Investigators

Kathy PaizisGiles WaltersMeg JardineCaroline MiltonAbu IbrahamBrian SilvaMichael DesmondVlado PerkovicJadadeesh KurtkotiEswari VilayurAlan CassShaun SummersFiona BrownJessica RyanPeter KerrEuan NobleGrant LuxtonDavid W MudgeCarmel HawleyDavid W JohnsonChen Au PehRandall J FaullDwarakanathan RanganathanLisa JeffsKathy NichollsPeter HughesBruce CooperNeil BoudvilleSharon FordRobyn LanghamDonna ReidlingerAlicia MorrishSunil V BadveElaine PascoePeta-Anne Paul-BrentLaura RobisonAndrea ValksDaniel BlockmansLiesbet HenckaertsBen SprangersRita SuriSoumeya BrachemiWilliam ClarkAmit GargSimon CaretteChristian PagnouxHeather ReichDavid BarthMichael WalshNader KhalidiGerry CoxAndrea Mazzetti

18

Evaluation of the Safety and Efficacy of Avacopan, a C5a Receptor Inhibitor, in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Treated Concomitantly With Rituximab or Cyclophosphamide/Azathioprine: Protocol for a Randomized, Double-Blind, Active-Controlled, Phase 3 Trial

JMIR Res Protoc. 2020 Apr 7;9(4):e16664. doi: 10.2196/16664.

Peter A Merkel 1 2David R Jayne 3Chao Wang 4Jan Hillson 5Pirow Bekker 5

19

Management of ANCA associated vasculitis

BMJ. 2020 Mar 18;368:m421. doi: 10.1136/bmj.m421.

Zachary S Wallace 1 2 3Eli M Miloslavsky 2 3

20

Complications of therapy for ANCA-associated vasculitis

Rheumatology (Oxford). 2020 May 1;59(Suppl 3):iii74-iii78. doi: 10.1093/rheumatology/kez618.

Rona Smith 1 2

21

Personalized Medicine in ANCA-Associated Vasculitis ANCA Specificity as the Guide?

Front Immunol. 2019 Dec 6;10:2855. doi: 10.3389/fimmu.2019.02855.eCollection 2019.

Zachary S Wallace 1 2 3 4John H Stone 2 3 4

22

All-cause and cause-specific mortality in ANCA-associated vasculitis: overall and according to ANCA type

Rheumatology (Oxford). 2020 Sep 1;59(9):2308-2315. doi: 10.1093/rheumatology/kez589.

Zachary S Wallace 1 2 3 4Xiaoqing Fu 1 2 3Tyler Harkness 1 2 3John H Stone 2 3 4Yuqing Zhang 1 2 3 4Hyon Choi 2 3 4

23

Genome-wide association study of eosinophilic granulomatosis with polyangiitis reveals genomic loci stratified by ANCA status

Nat Commun. 2019 Nov 12;10(1):5120. doi: 10.1038/s41467-019-12515-9.

Paul A Lyons 1 2James E Peters 1 3 4Federico Alberici 1 5 6James Liley 1 7Richard M R Coulson 1William Astle 3 7 8Chiara Baldini 9Francesco Bonatti 10Maria C Cid 11Heather Elding 12 13Giacomo Emmi 14Jörg Epplen 15Loïc Guillevin 16David R W Jayne 1Tao Jiang 3Iva Gunnarsson 17Peter Lamprecht 18Stephen Leslie 19 20Mark A Little 21Davide Martorana 10Frank Moosig 22Thomas Neumann 23 24Sophie Ohlsson 25Stefanie Quickert 23 26Giuseppe A Ramirez 27Barbara Rewerska 28Georg Schett 29Renato A Sinico 30Wojciech Szczeklik 28Vladimir Tesar 31Damjan Vukcevic 19 20European Vasculitis Genetics ConsortiumBenjamin Terrier 16Richard A Watts 32 33Augusto Vaglio 34Julia U Holle 22Chris Wallace 1 2 7Kenneth G C Smith 35 36

 

Collaborators

European Vasculitis Genetics Consortium: Mohammed AkilJonathan BarrattNeil BasuAdam S ButterworthIan BruceMichael ClarksonNiall ConlonBhaskar DasGuptaTimothy W R DoultonGeorgina Espígol-FrigoléOliver FlossmannArmando GabrielliJolanta GasiorGina GregoriniGiuseppe GuidaJosé Hernández-RodríguezZdenka HruskovaAmy HudsonAnn KnightPeter LanyonRaashid LuqmaniMalgorzata MaglianoAngelo A ManfrediChristopher MarguerieFederica MaritatiChiara MarvisiNeil J McHughEamonn MolloyAllan MotyerChetan MukhtyarLeonid PadyukovAlberto PesciSergio Prieto-GonzalezMarc Ramentol-SintasPetra ReisDario Roccatello

24

Long-term outcomes in elderly patients with ANCA-associated vasculitis

Rheumatology (Oxford). 2020 May 1;59(5):1076-1083. doi: 10.1093/rheumatology/kez388.

Dominic McGovern 1Sam P Williams 1Katrina Parsons 2Tariq E Farrah 1 3Peter J Gallacher 1 3Eve Miller-Hodges 1 3David C Kluth 1Robert W Hunter 1 3Neeraj Dhaun 1 3

25

Therapeutic options for patients with rare rheumatic diseases: a systematic review and meta-analysis

Orphanet J Rare Dis. 2020 Oct 31;15(1):308. doi: 10.1186/s13023-020-01576-5.

Tim T A Bender 1Judith Leyens 2Julia Sellin 1Dmitrij Kravchenko 3Rupert Conrad 4Martin Mücke 5Matthias F Seidel 6

26

Complementary Use of U.S. FDA's Adverse Event Reporting System and Sentinel System to Characterize Direct Oral Anticoagulants-Associated Cutaneous Small Vessel Vasculitis

Pharmacotherapy. 2020 Nov;40(11):1099-1107. doi: 10.1002/phar.2468. Epub 2020 Nov 8.

Mohamed Mohamoud 1Casie Horgan 2Efe Eworuke 3Elizabeth Dee 2Justin Bohn 2Oren Shapira 2Monica A Munoz 1Danijela Stojanovic 4Veronica Sansing-Foster 5Adebola Ajao 3Lois La Grenade 1

27

Low Utility of Radiological Imaging in Evaluating Cutaneous Small-Vessel Vasculitis: A Multi-institutional Retrospective Study

J Am Acad Dermatol. 2020 Oct 1;S0190-9622(20)32644-X. doi: 10.1016/j.jaad.2020.09.051.Online ahead of print.

Andrew C Walls 1Ryan S Din 1Jean-Phillip Okhovat 2Peter B Chansky 3Robert G Micheletti 3Arash Mostaghimi 1

28

An update on the microbiome in vasculitis

Curr Opin Rheumatol. 2021 Jan;33(1):15-23. doi: 10.1097/BOR.0000000000000758.

Shahna Tariq 1, Alison H Clifford

29

Systemic Lupus Erythematosus-associated Retinal Vasculitis Treated with Adalimumab

Ocul Immunol Inflamm. 2020 Nov 16;1-5. doi: 10.1080/09273948.2020.1828937.Online ahead of print.

Sanjana Kuthyar 1, Alexander C Barnes 1, Javeria Bhawal 2, Joseph Christiansen 1, Jessica G Shantha 1, Steven Yeh 1

30

Environmental risk factors associated with ANCA associated vasculitis: A systematic mapping review

Autoimmun Rev. 2020 Nov;19(11):102660. doi: 10.1016/j.autrev.2020.102660. Epub 2020 Sep 15.

Jennifer Scott 1, Jack Hartnett 1, David Mockler 2, Mark A Little 3

31

Morbidity and Mortality of Large-Vessel Vasculitides

Curr Rheumatol Rep. 2020 Oct 16;22(12):86. doi: 10.1007/s11926-020-00963-y.

Matthew J Koster 1, Kenneth J Warrington 2, Eric L Matteson 2

32

Vasculitis patient journey: a scoping review of patient experiences with vasculitis

Clin Rheumatol. 2020 Sep 30. doi: 10.1007/s10067-020-05398-5.Online ahead of print.

Navjeet Gill 1, Jan Willem Cohen Tervaert 2, Elaine Yacyshyn 3

33

Adjunctive Treatment With Avacopan, an Oral C5a Receptor Inhibitor, in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis

ACR Open Rheumatol. 2020 Nov;2(11):662-671. doi: 10.1002/acr2.11185. Epub 2020 Oct 31.

Peter A Merkel 1, John Niles 2, Richard Jimenez 3, Robert F Spiera 4, Brad H Rovin 5, Andrew Bomback 6, Christian Pagnoux 7, Antonia Potarca 8, Thomas J Schall 8, Pirow Bekker 8, CLASSIC Investigators

Collaborators

  • CLASSIC Investigators: 

Louis-Philippe Girard, Yih Chang Chen Lin, Galina Marder, Jennifer Murphy, William Shergy, Christopher Charles Striebich, Areena Swarup, James Tumlin

34

CanVasc consensus recommendations for the management of antineutrophil cytoplasm antibody-associated vasculitis: 2020 update

J Rheumatol. 2020 Sep 15;jrheum.200721. doi: 10.3899/jrheum.200721. Online ahead of print.

Arielle Mendel 1, Daniel Ennis 1, Ellen Go 1, Volodko Bakowsky 1, Corisande Baldwin 1, Susanne M Benseler 1, David A Cabral 1, Simon Carette 1, Marie Clements-Baker 1, Alison Clifford 1, Jan Willem Cohen Tervaert 1, Gerard Cox 1, Natasha Dehghan 1, Christine Dipchand 1, Navjot Dhindsa 1, Leilani Famorca 1, Aurore Fifi-Mah 1, Stephanie Garner 1, Louis-Philippe Girard 1, Clode Lessard 1, Patrick Liang 1, Damien Noone 1, Jean-Paul Makhzoum 1, Nataliya Milman 1, Christian A Pineau 1, Heather N Reich 1, Maxime Rhéaume 1, David B Robinson 1, Dax G Rumsey 1, Tanveer E Towheed 1, Judith Trudeau 1, Marinka Twilt 1, Elaine Yacyshyn 1, Rae Yeung 1, Lillian Barra 1, Nader Khalidi 1, Christian Pagnoux 1

35

Use and reporting of outcome measures in randomized trials for anti-neutrophil cytoplasmic antibody-associated vasculitis: a systematic literature review of randomized trials

Semin Arthritis Rheum. 2020 Sep 29;50(6):1314-1325.doi: 10.1016/j.semarthrit.2020.09.010. Online ahead of print.

Sara Monti 1, Kaitlin A Quinn 2, Robin Christensen 3, David Jayne 4, Carol Langford 5, Georgia E Lanier 6, Alfred Mahr 7, Christian Pagnoux 8, Maria Bjork Viðarsdóttir 9, Peter A Merkel 10, Gunnar Tomasson 11

36

Clinical Utility of Serial Measurements of Antineutrophil Cytoplasmic Antibodies Targeting Proteinase 3 in ANCA-Associated Vasculitis

Front Immunol. 2020 Sep 3;11:2053. doi: 10.3389/fimmu.2020.02053. eCollection 2020.

Gwen E Thompson 1 2, Lynn A Fussner 3, Amber M Hummel 2, Darrell R Schroeder 2, Francisco Silva 4, Melissa R Snyder 2, Carol A Langford 5, Peter A Merkel 6 7, Paul A Monach 8, Philip Seo 9, Robert F Spiera 10, E William St Clair 11, John H Stone 12, Ulrich Specks 2

37

ANCA-associated vasculitis

Nat Rev Dis Primers. 2020 Aug 27;6(1):71. doi: 10.1038/s41572-020-0204-y.

A Richard Kitching 1 2, Hans-Joachim Anders 3, Neil Basu 4, Elisabeth Brouwer 5, Jennifer Gordon 6, David R Jayne 7, Joyce Kullman 8, Paul A Lyons 7 9, Peter A Merkel 10, Caroline O S Savage 11, Ulrich Specks 12, Renate Kain 13

38

ANCA-associated vasculitides: Recommendations of the French Vasculitis Study Group on the use of immunosuppressants and biotherapies for remission induction and maintenance

Presse Med. 2020 Jul 6;49(3):104031. doi: 10.1016/j.lpm.2020.104031. Online ahead of print.

Benjamin Terrier 1, Pierre Charles 2, Olivier Aumaître 3, Alexandre Belot 4, Bernard Bonnotte 5, Yoann Crabol 6, Cécile-Audrey Durel 7, Mikael Ebbo 8, Noémie Jourde-Chiche 9, Jean-Christophe Lega 10, Xavier Puéchal 11, Grégory Pugnet 12, Thomas Quemeneur 13, Camillo Ribi 14, Maxime Samson 4, Frédéric Vandergheynst 15, Loïc Guillevin 11, French Vasculitis Study Group

39

2020 international consensus on ANCA testing beyond systemic vasculitis

Autoimmun Rev. 2020 Sep;19(9):102618. doi: 10.1016/j.autrev.2020.102618.Epub 2020 Jul 12.

Sergey Moiseev 1, Jan Willem Cohen Tervaert 2, Yoshihiro Arimura 3, Dimitrios P Bogdanos 4, Elena Csernok 5, Jan Damoiseaux 6, Marc Ferrante 7, Luis Felipe Flores-Suárez 8, Marvin J Fritzler 9, Pietro Invernizzi 10, David Jayne 11, J Charles Jennette 12, Mark A Little 13, Stephen P McAdoo 14, Pavel Novikov 15, Charles D Pusey 14, Antonella Radice 16, Alan D Salama 17, Judith A Savige 18, Mårten Segelmark 19, Yehuda Shoenfeld 20, Renato A Sinico 21, Maria-José Sousa 22, Ulrich Specks 23, Benjamin Terrier 24, Athanasios G Tzioufas 25, Severine Vermeire 7, Ming-Hui Zhao 26, Xavier Bossuyt 27

40

Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis

Ann Rheum Dis. 2020 Jun 24;annrheumdis-2019-216863.doi: 10.1136/annrheumdis-2019-216863. Online ahead of print.

Rona M Smith 1 2, Rachel Bronwen Jones 2, Ulrich Specks 3, Simon Bond 4, Marianna Nodale 4, Reem Aljayyousi 5, Jacqueline Andrews 6, Annette Bruchfeld 7, Brian Camilleri 8, Simon Carette 9, Chee Kay Cheung 10, Vimal Derebail 11, Tim Doulton 12, Lindsy Forbess 13, Shouichi Fujimoto 14, Shunsuke Furuta 15, Ora Gewurz-Singer 16, Lorraine Harper 17, Toshiko Ito-Ihara 18, Nader Khalidi 19, Rainer Klocke 20, Curry Koening 21, Yoshinori Komagata 22, Carol Langford 23, Peter Lanyon 24, Raashid Ahmed Luqmani 25, Hirofumi Makino 26, Carole McAlear 27, Paul Monach 28, Larry W Moreland 29, Kim Mynard 2, Patrick Nachman 11, Christian Pagnoux 30, Fiona Pearce 31, Chen Au Peh 32, Charles Pusey 33, Dwarakanathan Ranganathan 34, Rennie L Rhee 35, Robert Spiera 36, Antoine G Sreih 37, Vladimir Tesar 38, Giles Walters 39, Michael H Weisman 13, Caroline Wroe 40, Peter Merkel 41, David Jayne 42 2, RITAZAREM coinvestigators; RITAZAREM co-investigators

 

Collaborators

Y Arimura, M Clarkson, J de Zoysa, T Endo, Y Hamano, H Kono, S Lawman, E Muso, K Sada, R Smith, K Suzuki, T Tsukamoto, S Uchida, A Vaglio, R Watts

41

Epidemiology, Time-trends and Outcomes of Serious Infections in Patients With Vasculitis: A 19-year National Study

Arthritis Care Res (Hoboken). 2020 Jun 11.doi: 10.1002/acr.24348. Online ahead of print.

Jasvinder A Singh 1 2 3, John D Cleveland 2

42

Utility of the Brief Illness Perception Questionnaire to Monitor Patient Beliefs in Systemic Vasculitis

Rheumatol. 2020 Apr 1;jrheum.190828. doi: 10.3899/jrheum.190828. Online ahead of print.

Mollie N Schwartz 1, Casey A Rimland 1, Kaitlin A Quinn 1, Marcela Ferrada 1, K Bates Gribbons 1, Joel S Rosenblum 1, Wendy Goodspeed 1, Elaine Novakovich 1, Peter C Grayson 1

43

Treatment Outcomes of Anti-Neutrophil Cytoplasmic Autoantibody-Associated Vasculitis in Patients Over Age 75 Years: A Meta-Analysis

Morris AD1, Elsayed ME2, Ponnusamy A2, Rowbottom A3, Martin F4, Geetha D5, Dhaygude AP2. Am J Nephrol. 2020 Mar 11:1-9. doi: 10.1159/000506532. [Epub ahead of print]

44

Complications of therapy for ANCA-associated vasculitis

Smith R1,2. Rheumatology (Oxford). 2020 Jan 20. pii: kez618. doi: 10.1093/rheumatology/kez618. [Epub ahead of print]

45

All-cause and cause-specific mortality in ANCA-associated vasculitis: overall and according to ANCA type

Wallace ZS1,2,3,4, Fu X1,2,3, Harkness T1,2,3, Stone JH2,3,4, Zhang Y1,2,3,4, Choi H2,3,4. Rheumatology (Oxford). 2019 Dec 17. pii: kez589. doi: 10.1093/rheumatology/kez589. [Epub ahead of print]

46

Long-term outcomes in elderly patients with ANCA-associated vasculitis

McGovern D1, Williams SP1, Parsons K2, Farrah TE1,3, Gallacher PJ1,3, Miller-Hodges E1,3, Kluth DC1, Hunter RW1,3, Dhaun N1,3. Rheumatology (Oxford). 2019 Sep 17. pii: kez388. doi: 10.1093/rheumatology/kez388. [Epub ahead of print]

47

Personalized Medicine in ANCA-Associated Vasculitis ANCA Specificity as the Guide?

Wallace ZS1,2,3,4, Stone JH2,3,4. Front Immunol. 2019 Dec 6;10:2855. doi: 10.3389/fimmu.2019.02855. eCollection 2019.

48

Anti-neutrophil Cytoplasmic Antibodies (ANCA) as Disease Activity Biomarkers in a "Personalized Medicine Approach" in ANCA-Associated Vasculitis

Osman MS1, Tervaert JWC2. Curr Rheumatol Rep. 2019 Dec 26;21(12):76. doi: 10.1007/s11926-019-0872-3.

49

Remission maintenance in ANCA-associated vasculitis: does one size fit all?

Berti A1,2, Specks U2. Expert Rev Clin Immunol. 2019 Dec;15(12):1273-1286. doi: 10.1080/1744666X.2020.1693260. Epub 2019 Nov 24.